news

 

Nishimura & Asahi has advised Japanese life insurance giant Dai-ichi Life Holdings on its 2.9-trillion-yen ($2 billion) acquisition of healthcare platform Benefit One, which was represented by Mori Hamada & Matsumoto.

Dai-ichi has been expanding its non-insurance business as its life insurance business struggles due to Japan’s shrinking population, Nikkei reported.

The Nishimura team was led by partners Yamato Nozawa and Junya Kokaji.

The MHM team included partners Takeshi Okuyama and Hideki Ben.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

GT, Goodwin act as Japan's Ono buys U.S. drugmaker for $2.4 bln

Greenberg Traurig has represented Japan’s Ono Pharmaceutical Co on its $2.4 billion acquisition of  U.S.-based cancer drugmaker Deciphera, which was advised by Goodwin Procter.

R&T, WongP, Lee & Lee advise on $595 mln TCM deal

by Nimitt Dixit |

Singapore law firms WongPartnership, Lee & Lee and Rajah & Tann (R&T), and R&T’s Malaysian member firm Christopher & Lee Ong have advised traditional Chinese medicine firm Eu Yan Sang International (EYS) and its shareholders on the sale of 86 percent of EYS’ shares.

Skadden advises Cemex on $650 mln Philippines divestment

by Nimitt Dixit |

U.S. law firm Skadden, Arps, Slate, Meagher & Flom has advised Mexico-based multinational building materials company Cemex on the sale of its operations and assets in the Philippines to Dacon Corporation, DMCI Holdings, and Seminara Mining and Power Corporation.